Portfolio – JStar Capital

JStar Capital

Our investments

Our portfolio features top-tier innovators who lead the competitive MedTech market. Through our support and strategic guidance, they drive significant industry change and achieve sustainable growth, cementing their status as MedTech market pioneers.

Sonavex

Sonavex’s patented EchoMark and EchoSure technology enables care team members to collect arteriovenous fistula volumetric flow rate, diameter, and depth information at dialysis clinics to support maturation assessment.

Adhere Plus - Painscript

Adhere Plus connects physicians with chronic pain and SUD patients by tracking medication and care plan adherence through a clinically-validated app. Physicians receive detailed patient insight, a HIPAA-compliant clinical dashboard, and tools for medication monitoring.

OsteoCentric

OsteoCentric's UnifiMI® technology offers instant and lasting multi-axial stability by mechanically integrating with bone, making it effective in both orthopedics and dental applications. Its proprietary thread geometry ensures primary implant stability in normal, compromised, and osteoporotic bone.

Vega Surgical Systems

Vega Surgical's Xcape port and Axis Drill treat Chronic Subdural Hematomas more effectively than current OR surgeries or bedside procedures. By combining the effectiveness of the operating room with the efficiency of bedside procedures, Vega reduces costs and enhances patient outcomes.

Prior investments under Grassroot Capital Investments

Companies previously invested in by our prior SPV fund, Grassroot Capital Investments.

BioStar Capital

Biostar Capital is a venture capital firm specializing in transformative medical technologies, uniquely composed of healthcare clinicians, executives, and financial professionals. With $20M raised and is the single largest investor with five venture funds, focused on cardiology, orthopedics, and robotics, driven by their mission to improve patients' lives while delivering strong investor returns.

ICS - Emblok

Emblok is a fully funded 16M dollar round as the sole investor. It is an embolic protection system providing full circumferential aortic coverage and complete protection during TAVR deployment. Its mesh filter allows blood flow while capturing and removing embolic debris, ensuring cerebral and body protection.

A Biostar Portfolio Company

This is an early-stage medical device company pioneering a unique technology in the cardiovascular space.